Glenmede Trust CO Na Vericel Corp Transaction History
Glenmede Trust CO Na
- $18.2 Billion
- Q1 2025
A detailed history of Glenmede Trust CO Na transactions in Vericel Corp stock. As of the latest transaction made, Glenmede Trust CO Na holds 10,832 shares of VCEL stock, worth $392,551. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,832
Previous 10,882
0.46%
Holding current value
$392,551
Previous $597,000
19.1%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding VCEL
# of Institutions
290Shares Held
54.2MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$292 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$127 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.88MShares$104 Million3.98% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$89.3 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$88.3 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.71B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...